Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1

Rosa Gasa, Catherine Clark, Ruojing Yang, Anna De Paoli-Roach, Christopher B. Newgard

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Glycogen-targeting subunits of protein phosphatase-1 facilitate interaction of the phosphatase with enzymes of glycogen metabolism. Expression of one family member, PTG, in the liver of normal rats improves glucose tolerance without affecting other plasma variables but leaves animals unable to reduce hepatic glycogen stores in response to fasting. In the current study, we have tested whether expression of other targeting subunit isoforms, such as the liver isoform GL, the muscle isoform GM/RGl, or a truncated version of GM/RGl termed GMΔC in liver ameliorates glucose intolerance in rats fed on a high fat diet (HF). HF animals overexpressing GMΔC, but not GL or GM/RGl, exhibited a decline in blood glucose of 35-44 mg/dl relative to control HF animals during an oral glucose tolerance test (OGTT) such that levels were indistinguishable from those of normal rats fed on standard chow at all but one time point. Hepatic glycogen levels were 2.1-2.4-fold greater in GL- and GMΔC-overexpressing HF rats compared with control HF animals following OGTT. In a second set of studies on fed and 20-h fasted HF animals, GMΔC-overexpressing rats lowered their liver glycogen levels by 57% (from 402 ± 54 to 173 ± 27 μg of glycogen/mg of protein) in the fasted versus fed states compared with only 44% in GL-overexpressing animals (from 740 ± 35 to 413 ± 141 μg of glycogen/mg of protein). Since the OGTT studies were performed on 20-h fasted rats, this meant that GMΔC-overexpressing rats synthesized much more glycogen than GL-overexpressing HF rats during the OGTT (419 versus 117 μg of glycogen/mg of protein, respectively), helping to explain why GMΔC preferentially enhanced glucose clearance. We conclude that GMΔC has a unique combination of glycogenic potency and responsiveness to glycogenolytic signals that allows it to be used to lower blood glucose levels in diabetes.

Original languageEnglish (US)
Pages (from-to)1524-1530
Number of pages7
JournalJournal of Biological Chemistry
Volume277
Issue number2
DOIs
StatePublished - Jan 11 2002
Externally publishedYes

Fingerprint

Protein Phosphatase 1
Glucose Intolerance
Nutrition
Glycogen
High Fat Diet
Rats
Diet
Fats
Glucose
Animals
Liver
Glucose Tolerance Test
Liver Glycogen
Protein Isoforms
Blood Glucose
Proteins
Medical problems
Phosphoric Monoester Hydrolases
Metabolism
Muscle

ASJC Scopus subject areas

  • Biochemistry

Cite this

Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1. / Gasa, Rosa; Clark, Catherine; Yang, Ruojing; De Paoli-Roach, Anna; Newgard, Christopher B.

In: Journal of Biological Chemistry, Vol. 277, No. 2, 11.01.2002, p. 1524-1530.

Research output: Contribution to journalArticle

@article{5035528140a64df196e31c2ecc65d146,
title = "Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1",
abstract = "Glycogen-targeting subunits of protein phosphatase-1 facilitate interaction of the phosphatase with enzymes of glycogen metabolism. Expression of one family member, PTG, in the liver of normal rats improves glucose tolerance without affecting other plasma variables but leaves animals unable to reduce hepatic glycogen stores in response to fasting. In the current study, we have tested whether expression of other targeting subunit isoforms, such as the liver isoform GL, the muscle isoform GM/RGl, or a truncated version of GM/RGl termed GMΔC in liver ameliorates glucose intolerance in rats fed on a high fat diet (HF). HF animals overexpressing GMΔC, but not GL or GM/RGl, exhibited a decline in blood glucose of 35-44 mg/dl relative to control HF animals during an oral glucose tolerance test (OGTT) such that levels were indistinguishable from those of normal rats fed on standard chow at all but one time point. Hepatic glycogen levels were 2.1-2.4-fold greater in GL- and GMΔC-overexpressing HF rats compared with control HF animals following OGTT. In a second set of studies on fed and 20-h fasted HF animals, GMΔC-overexpressing rats lowered their liver glycogen levels by 57{\%} (from 402 ± 54 to 173 ± 27 μg of glycogen/mg of protein) in the fasted versus fed states compared with only 44{\%} in GL-overexpressing animals (from 740 ± 35 to 413 ± 141 μg of glycogen/mg of protein). Since the OGTT studies were performed on 20-h fasted rats, this meant that GMΔC-overexpressing rats synthesized much more glycogen than GL-overexpressing HF rats during the OGTT (419 versus 117 μg of glycogen/mg of protein, respectively), helping to explain why GMΔC preferentially enhanced glucose clearance. We conclude that GMΔC has a unique combination of glycogenic potency and responsiveness to glycogenolytic signals that allows it to be used to lower blood glucose levels in diabetes.",
author = "Rosa Gasa and Catherine Clark and Ruojing Yang and {De Paoli-Roach}, Anna and Newgard, {Christopher B.}",
year = "2002",
month = "1",
day = "11",
doi = "10.1074/jbc.M107744200",
language = "English (US)",
volume = "277",
pages = "1524--1530",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1

AU - Gasa, Rosa

AU - Clark, Catherine

AU - Yang, Ruojing

AU - De Paoli-Roach, Anna

AU - Newgard, Christopher B.

PY - 2002/1/11

Y1 - 2002/1/11

N2 - Glycogen-targeting subunits of protein phosphatase-1 facilitate interaction of the phosphatase with enzymes of glycogen metabolism. Expression of one family member, PTG, in the liver of normal rats improves glucose tolerance without affecting other plasma variables but leaves animals unable to reduce hepatic glycogen stores in response to fasting. In the current study, we have tested whether expression of other targeting subunit isoforms, such as the liver isoform GL, the muscle isoform GM/RGl, or a truncated version of GM/RGl termed GMΔC in liver ameliorates glucose intolerance in rats fed on a high fat diet (HF). HF animals overexpressing GMΔC, but not GL or GM/RGl, exhibited a decline in blood glucose of 35-44 mg/dl relative to control HF animals during an oral glucose tolerance test (OGTT) such that levels were indistinguishable from those of normal rats fed on standard chow at all but one time point. Hepatic glycogen levels were 2.1-2.4-fold greater in GL- and GMΔC-overexpressing HF rats compared with control HF animals following OGTT. In a second set of studies on fed and 20-h fasted HF animals, GMΔC-overexpressing rats lowered their liver glycogen levels by 57% (from 402 ± 54 to 173 ± 27 μg of glycogen/mg of protein) in the fasted versus fed states compared with only 44% in GL-overexpressing animals (from 740 ± 35 to 413 ± 141 μg of glycogen/mg of protein). Since the OGTT studies were performed on 20-h fasted rats, this meant that GMΔC-overexpressing rats synthesized much more glycogen than GL-overexpressing HF rats during the OGTT (419 versus 117 μg of glycogen/mg of protein, respectively), helping to explain why GMΔC preferentially enhanced glucose clearance. We conclude that GMΔC has a unique combination of glycogenic potency and responsiveness to glycogenolytic signals that allows it to be used to lower blood glucose levels in diabetes.

AB - Glycogen-targeting subunits of protein phosphatase-1 facilitate interaction of the phosphatase with enzymes of glycogen metabolism. Expression of one family member, PTG, in the liver of normal rats improves glucose tolerance without affecting other plasma variables but leaves animals unable to reduce hepatic glycogen stores in response to fasting. In the current study, we have tested whether expression of other targeting subunit isoforms, such as the liver isoform GL, the muscle isoform GM/RGl, or a truncated version of GM/RGl termed GMΔC in liver ameliorates glucose intolerance in rats fed on a high fat diet (HF). HF animals overexpressing GMΔC, but not GL or GM/RGl, exhibited a decline in blood glucose of 35-44 mg/dl relative to control HF animals during an oral glucose tolerance test (OGTT) such that levels were indistinguishable from those of normal rats fed on standard chow at all but one time point. Hepatic glycogen levels were 2.1-2.4-fold greater in GL- and GMΔC-overexpressing HF rats compared with control HF animals following OGTT. In a second set of studies on fed and 20-h fasted HF animals, GMΔC-overexpressing rats lowered their liver glycogen levels by 57% (from 402 ± 54 to 173 ± 27 μg of glycogen/mg of protein) in the fasted versus fed states compared with only 44% in GL-overexpressing animals (from 740 ± 35 to 413 ± 141 μg of glycogen/mg of protein). Since the OGTT studies were performed on 20-h fasted rats, this meant that GMΔC-overexpressing rats synthesized much more glycogen than GL-overexpressing HF rats during the OGTT (419 versus 117 μg of glycogen/mg of protein, respectively), helping to explain why GMΔC preferentially enhanced glucose clearance. We conclude that GMΔC has a unique combination of glycogenic potency and responsiveness to glycogenolytic signals that allows it to be used to lower blood glucose levels in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0037059763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037059763&partnerID=8YFLogxK

U2 - 10.1074/jbc.M107744200

DO - 10.1074/jbc.M107744200

M3 - Article

C2 - 11707447

AN - SCOPUS:0037059763

VL - 277

SP - 1524

EP - 1530

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -